DHG Pharmaceutical JSC Statistics

Total Valuation

DHG Pharmaceutical JSC has a market cap or net worth of VND 13.27 trillion. The enterprise value is 11.11 trillion.

Market Cap	13.27T
Enterprise Value	11.11T

Important Dates

The last earnings date was Monday, January 20, 2025.

Earnings Date	Jan 20, 2025
Ex-Dividend Date	Dec 24, 2024

Share Statistics

DHG Pharmaceutical JSC has 130.75 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	130.75M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.07%
Owned by Insiders (%)	8.18%
Owned by Institutions (%)	0.44%
Float	n/a

Valuation Ratios

The trailing PE ratio is 17.61 and the forward PE ratio is 12.64.

PE Ratio	17.61
Forward PE	12.64
PS Ratio	2.72
PB Ratio	3.24
P/TBV Ratio	3.39
P/FCF Ratio	10.80
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.20, with an EV/FCF ratio of 9.04.

EV / Earnings	14.75
EV / Sales	2.27
EV / EBITDA	10.20
EV / EBIT	12.08
EV / FCF	9.04

Financial Position

The company has a current ratio of 2.57, with a Debt / Equity ratio of 0.16.

Current Ratio	2.57
Quick Ratio	1.91
Debt / Equity	0.16
Debt / EBITDA	0.60
Debt / FCF	0.53
Interest Coverage	37.09

Financial Efficiency

Return on equity (ROE) is 17.41% and return on invested capital (ROIC) is 11.31%.

Return on Equity (ROE)	17.41%
Return on Assets (ROA)	9.53%
Return on Capital (ROIC)	11.31%
Revenue Per Employee	1.75B
Profits Per Employee	269.51M
Employee Count	2,789
Asset Turnover	0.81
Inventory Turnover	2.07

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.18% in the last 52 weeks. The beta is 0.54, so DHG Pharmaceutical JSC's price volatility has been lower than the market average.

Beta (5Y)	0.54
52-Week Price Change	-2.18%
50-Day Moving Average	103,552.00
200-Day Moving Average	109,283.50
Relative Strength Index (RSI)	46.60
Average Volume (20 Days)	19,300

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DHG Pharmaceutical JSC had revenue of VND 4.88 trillion and earned 753.55 billion in profits. Earnings per share was 5,763.48.

Revenue	4.88T
Gross Profit	2.14T
Operating Income	920.28B
Pretax Income	904.48B
Net Income	753.55B
EBITDA	1.09T
EBIT	920.28B
Earnings Per Share (EPS)	5,763.48

Full Income Statement

Balance Sheet

The company has 2.81 trillion in cash and 649.91 billion in debt, giving a net cash position of 2.16 trillion or 16,504.84 per share.

Cash & Cash Equivalents	2.81T
Total Debt	649.91B
Net Cash	2.16T
Net Cash Per Share	16,504.84
Equity (Book Value)	4.09T
Book Value Per Share	31,318.38
Working Capital	2.81T

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.32 trillion and capital expenditures -88.70 billion, giving a free cash flow of 1.23 trillion.

Operating Cash Flow	1.32T
Capital Expenditures	-88.70B
Free Cash Flow	1.23T
FCF Per Share	9,398.97

Full Cash Flow Statement

Margins

Gross margin is 43.76%, with operating and profit margins of 18.84% and 15.95%.

Gross Margin	43.76%
Operating Margin	18.84%
Pretax Margin	18.52%
Profit Margin	15.95%
EBITDA Margin	22.31%
EBIT Margin	18.84%
FCF Margin	25.16%

Dividends & Yields

This stock pays an annual dividend of 7,500.00, which amounts to a dividend yield of 7.39%.

Dividend Per Share	7,500.00
Dividend Yield	7.39%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	125.89%
Buyback Yield	n/a
Shareholder Yield	7.39%
Earnings Yield	5.68%
FCF Yield	9.26%

Dividend Details

Stock Splits

The last stock split was on May 26, 2017. It was a forward split with a ratio of 1.5.

Last Split Date	May 26, 2017
Split Type	Forward
Split Ratio	1.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a